Govt caps trade margins on non-scheduled anti-cancer drugs at 30% of MRP | India News
NEW DELHI: The government on Thursday decided to cap trade margins at 30% of the maximum retail price (MRP) for all non-scheduled anti-cancer drugs, according to official sources cited by ANI.The decision will cover branded and generic medicines, as well as domestic and imported drugs, including patented and non-patented medicines. The government said the move…
